Yaovalux Chamgramol

915 total citations
34 papers, 683 citations indexed

About

Yaovalux Chamgramol is a scholar working on Surgery, Oncology and Cancer Research. According to data from OpenAlex, Yaovalux Chamgramol has authored 34 papers receiving a total of 683 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Surgery, 15 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Yaovalux Chamgramol's work include Cholangiocarcinoma and Gallbladder Cancer Studies (20 papers), Pediatric Hepatobiliary Diseases and Treatments (7 papers) and Peptidase Inhibition and Analysis (7 papers). Yaovalux Chamgramol is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (20 papers), Pediatric Hepatobiliary Diseases and Treatments (7 papers) and Peptidase Inhibition and Analysis (7 papers). Yaovalux Chamgramol collaborates with scholars based in Thailand, Japan and Australia. Yaovalux Chamgramol's co-authors include Chawalit Pairojkul, Banchob Sripa, Jason Mulvenna, Natini Jinawath, Yoichi Furukawa, Tatsuhiko Tsunoda, Yusuke Nakamura, Kazutaka Obama, Somchai Pinlaor and Sopit Wongkham and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Oncogene.

In The Last Decade

Yaovalux Chamgramol

33 papers receiving 676 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yaovalux Chamgramol Thailand 15 325 316 202 175 95 34 683
Krishna Patel India 16 197 0.6× 312 1.0× 264 1.3× 183 1.0× 83 0.9× 44 737
Yuan Hu China 15 71 0.2× 183 0.6× 150 0.7× 69 0.4× 89 0.9× 52 584
Mohsin Ali Canada 11 48 0.1× 369 1.2× 109 0.5× 84 0.5× 96 1.0× 23 576
Stéphanie Villar France 17 135 0.4× 247 0.8× 177 0.9× 288 1.6× 76 0.8× 34 752
Ruth Anway United States 7 141 0.4× 172 0.5× 366 1.8× 37 0.2× 264 2.8× 11 696
Michael Locketz South Africa 10 184 0.6× 172 0.5× 140 0.7× 62 0.4× 20 0.2× 19 677
Jing Geng China 14 57 0.2× 289 0.9× 114 0.6× 60 0.3× 36 0.4× 34 607
Kwang‐Won Hong South Korea 15 118 0.4× 603 1.9× 147 0.7× 112 0.6× 20 0.2× 39 1.1k
Nupur Mukherjee India 17 45 0.1× 415 1.3× 202 1.0× 154 0.9× 68 0.7× 33 689
Thomas J. Rea United States 17 325 1.0× 268 0.8× 140 0.7× 167 1.0× 31 0.3× 24 815

Countries citing papers authored by Yaovalux Chamgramol

Since Specialization
Citations

This map shows the geographic impact of Yaovalux Chamgramol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaovalux Chamgramol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaovalux Chamgramol more than expected).

Fields of papers citing papers by Yaovalux Chamgramol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaovalux Chamgramol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaovalux Chamgramol. The network helps show where Yaovalux Chamgramol may publish in the future.

Co-authorship network of co-authors of Yaovalux Chamgramol

This figure shows the co-authorship network connecting the top 25 collaborators of Yaovalux Chamgramol. A scholar is included among the top collaborators of Yaovalux Chamgramol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaovalux Chamgramol. Yaovalux Chamgramol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vaeteewoottacharn, Kulthida, Paweena Dana, Sittiruk Roytrakul, et al.. (2025). Cholangiocarcinoma-derived secreted products and growth arrest-specific 2-like 3 enhance migratory and invasive abilities of fibroblasts. European Journal of Cell Biology. 104(3). 151507–151507. 1 indexed citations
2.
Deenonpoe, Raksawan, Watcharin Loilome, Poramate Klanrit, et al.. (2025). Identifying a unique chromosomal pattern to predict the gemcitabine response in patients with cholangiocarcinoma. Scientific Reports. 15(1). 11984–11984.
3.
Chamgramol, Yaovalux, et al.. (2023). RET rearrangements are relevant to histopathologic subtypes and clinicopathological features in Thai papillary thyroid carcinoma patients. Pathology & Oncology Research. 29. 1611138–1611138. 4 indexed citations
4.
Waraasawapati, Sakda, Yaovalux Chamgramol, Kanlayanee Sawanyawisuth, et al.. (2023). Dense GM-CSFR α -expressing immune infiltration is allied with longer survival of intrahepatic cholangiocarcinoma patients. PeerJ. 11. e14883–e14883. 1 indexed citations
5.
Kariya, Ryusho, Kanlayanee Sawanyawisuth, Ubon Cha’on, et al.. (2023). Diminishing acetyl-CoA carboxylase 1 attenuates CCA migration via AMPK-NF-κB-snail axis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1869(5). 166694–166694. 7 indexed citations
6.
Deenonpoe, Raksawan, Malinee Thanee, Kitti Intuyod, et al.. (2022). Fluorescence in situ hybridization detection of chromosome 7 and/or 17 polysomy as a prognostic marker for cholangiocarcinoma. Scientific Reports. 12(1). 8441–8441. 2 indexed citations
7.
Priprem, Aroonsri, Kitti Intuyod, Chawalit Pairojkul, et al.. (2021). Curcumin-loaded nanocomplexes: Acute and chronic toxicity studies in mice and hamsters. Toxicology Reports. 8. 1346–1357. 31 indexed citations
8.
Sripa, Banchob, Wunchana Seubwai, Kulthida Vaeteewoottacharn, et al.. (2020). Functional and genetic characterization of three cell lines derived from a single tumor of an Opisthorchis viverrini-associated cholangiocarcinoma patient. Human Cell. 33(3). 695–708. 93 indexed citations
9.
Vaeteewoottacharn, Kulthida, Chawalit Pairojkul, Ryusho Kariya, et al.. (2019). Establishment of Highly Transplantable Cholangiocarcinoma Cell Lines from a Patient-Derived Xenograft Mouse Model. Cells. 8(5). 496–496. 30 indexed citations
10.
Deenonpoe, Raksawan, Eimorn Mairiang, Pisaln Mairiang, et al.. (2017). Elevated prevalence of Helicobacter species and virulence factors in opisthorchiasis and associated hepatobiliary disease. Scientific Reports. 7(1). 42744–42744. 43 indexed citations
11.
Chamgramol, Yaovalux, et al.. (2016). Clinicopathological Significance of Osteopontin in Cholangiocarcinoma Cases. Asian Pacific Journal of Cancer Prevention. 17(1). 201–205. 13 indexed citations
12.
Pinlaor, Somchai, Lakhanawan Charoensuk, Puangrat Yongvanit, et al.. (2015). MRI and 1H MRS findings of hepatobilary changes and cholangiocarcinoma development in hamsters infected with Opisthorchis viverrini and treated with N-nitrosodimethylamine. Magnetic Resonance Imaging. 33(9). 1146–1155. 3 indexed citations
13.
Mairiang, Eimorn, et al.. (2014). An Interleukin-6 Receptor Polymorphism is Associated with Opisthorchiasis-Linked Cholangiocarcinoma Risk in Thailand. Asian Pacific Journal of Cancer Prevention. 15(13). 5443–5447. 8 indexed citations
14.
Hongsrichan, Nuttanan, Yaovalux Chamgramol, Porntip Pinlaor, et al.. (2013). Increase of exostosin 1 in plasma as a potential biomarker for opisthorchiasis-associated cholangiocarcinoma. Tumor Biology. 35(2). 1029–1039. 22 indexed citations
15.
Yonglitthipagon, Ponlapat, Chawalit Pairojkul, Yaovalux Chamgramol, et al.. (2012). Prognostic significance of peroxiredoxin 1 and ezrin-radixin-moesin–binding phosphoprotein 50 in cholangiocarcinoma. Human Pathology. 43(10). 1719–1730. 30 indexed citations
16.
Wu, Zhiliang, Thidarut Boonmars, Isao Nagano, et al.. (2012). Alteration of galectin-1 during tumorigenesis of Opisthorchis viverrini infection-induced cholangiocarcinoma and its correlation with clinicopathology. Tumor Biology. 33(4). 1169–1178. 7 indexed citations
17.
Hahnvajanawong, Chariya, Wongwarut Boonyanugomol, Kovit Pattanapanyasat, et al.. (2011). Inhibition of cell cycle progression and apoptotic activity of resveratrol in human intrahepatic cholangiocarcinoma cell lines. Asian Biomedicine. 5(6). 775–786. 6 indexed citations
18.
Boonmars, Thidarut, Yaovalux Chamgramol, Chantana Aromdee, et al.. (2011). Comparative studies on animal models for Opisthorchis viverrini infection: host interaction through susceptibility and pathology. Parasitology Research. 110(3). 1213–1223. 15 indexed citations
19.
Yonglitthipagon, Ponlapat, Chawalit Pairojkul, Yaovalux Chamgramol, Jason Mulvenna, & Banchob Sripa. (2010). Up-regulation of annexin A2 in cholangiocarcinoma caused by Opisthorchis viverrini and its implication as a prognostic marker. International Journal for Parasitology. 40(10). 1203–1212. 34 indexed citations
20.
Jinawath, Natini, Yaovalux Chamgramol, Yoichi Furukawa, et al.. (2006). Comparison of gene expression profiles between Opisthorchis viverrini and non‐Opisthorchis viverrini associated human intrahepatic cholangiocarcinoma†. Hepatology. 44(4). 1025–1038. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026